E Kr̆epela

1.8k total citations
46 papers, 1.5k citations indexed

About

E Kr̆epela is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, E Kr̆epela has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 17 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in E Kr̆epela's work include Peptidase Inhibition and Analysis (27 papers), Protease and Inhibitor Mechanisms (15 papers) and Neuropeptides and Animal Physiology (9 papers). E Kr̆epela is often cited by papers focused on Peptidase Inhibition and Analysis (27 papers), Protease and Inhibitor Mechanisms (15 papers) and Neuropeptides and Animal Physiology (9 papers). E Kr̆epela collaborates with scholars based in Czechia, India and Russia. E Kr̆epela's co-authors include Aleksi Šedo, Pavel Fiala, Petr Zatloukal, A Kubík, Jurij Rozhin, Bonnie F. Sloane, Kamiar Moin, E Kasafírek, Libor Havel and Luboš Petruželka and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Cell Science and International Journal of Molecular Sciences.

In The Last Decade

E Kr̆epela

46 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Kr̆epela Czechia 20 710 499 424 384 177 46 1.5k
Yuzo Furuya Japan 22 510 0.7× 923 1.8× 731 1.7× 359 0.9× 60 0.3× 83 1.9k
Bianca Maria Veneziani Italy 22 821 1.2× 1.0k 2.1× 689 1.6× 338 0.9× 43 0.2× 51 2.0k
Yoko Takagi Japan 22 490 0.7× 922 1.8× 255 0.6× 388 1.0× 120 0.7× 46 1.6k
Lars Damstrup Denmark 19 910 1.3× 902 1.8× 452 1.1× 226 0.6× 35 0.2× 43 1.9k
Grégoire Prévost France 24 645 0.9× 1.0k 2.0× 107 0.3× 239 0.6× 98 0.6× 56 1.7k
Daqing Wu United States 24 460 0.6× 942 1.9× 329 0.8× 279 0.7× 37 0.2× 56 1.7k
M Mabry United States 18 667 0.9× 835 1.7× 284 0.7× 266 0.7× 29 0.2× 26 1.5k
George Van Buren United States 21 1.4k 2.0× 968 1.9× 321 0.8× 583 1.5× 113 0.6× 52 2.2k
Peter Shintaku United States 19 630 0.9× 1.0k 2.0× 190 0.4× 553 1.4× 35 0.2× 30 1.9k
Julie Litz United States 18 511 0.7× 885 1.8× 144 0.3× 155 0.4× 67 0.4× 20 1.4k

Countries citing papers authored by E Kr̆epela

Since Specialization
Citations

This map shows the geographic impact of E Kr̆epela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Kr̆epela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Kr̆epela more than expected).

Fields of papers citing papers by E Kr̆epela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Kr̆epela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Kr̆epela. The network helps show where E Kr̆epela may publish in the future.

Co-authorship network of co-authors of E Kr̆epela

This figure shows the co-authorship network connecting the top 25 collaborators of E Kr̆epela. A scholar is included among the top collaborators of E Kr̆epela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Kr̆epela. E Kr̆epela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Syrůček, Martin, Robert Tomáš, Zdislava Vaníčková, et al.. (2023). Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours. Pathology. 55(6). 806–817. 16 indexed citations
2.
Kr̆epela, E, Vera S. Donnenberg, Albert D. Donnenberg, et al.. (2017). BOK displays cell death‐independent tumor suppressor activity in non‐small‐cell lung carcinoma. International Journal of Cancer. 141(10). 2050–2061. 23 indexed citations
3.
Kr̆epela, E, et al.. (2017). Species-specific real-time RT-PCR analysis of expression of stromal cell genes in a tumor xenotransplantation model in mice. Biochemical and Biophysical Research Communications. 491(1). 126–133. 6 indexed citations
4.
Kr̆epela, E, et al.. (2014). Differential sensitivity to apoptosome apparatus activation in non-small cell lung carcinoma and the lung. International Journal of Oncology. 44(5). 1443–1454. 10 indexed citations
5.
Bušek, Petr, Jarmila Stremenova Spegarova, Eva Balážiová, et al.. (2012). Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity. The International Journal of Biochemistry & Cell Biology. 44(5). 738–747. 32 indexed citations
6.
Spegarova, Jarmila Stremenova, Vladislav Mareš, Věra Lisá, et al.. (2010). Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.. PubMed. 36(2). 351–8. 15 indexed citations
7.
Bušek, Petr, et al.. (2006). Expression and Function of Dipeptidyl Peptidase IV and Related Enzymes in Cancer. Advances in experimental medicine and biology. 575. 55–62. 4 indexed citations
8.
Kr̆epela, E, et al.. (2005). Expression of apoptosome pathway-related transcripts in non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 132(1). 57–68. 21 indexed citations
9.
Kr̆epela, E, et al.. (2004). Increased expression of Apaf-1 and procaspase-3 and the functionality of intrinsic apoptosis apparatus in non-small cell lung carcinoma. Biological Chemistry. 385(2). 153–168. 49 indexed citations
10.
Zatloukal, Petr, Luboš Petruželka, Milada Zemanová, et al.. (2004). Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer. 46(1). 87–98. 329 indexed citations
11.
Pauk, Norbert, A Kubík, Petr Zatloukal, & E Kr̆epela. (2004). Lung cancer in women. Lung Cancer. 48(1). 1–9. 52 indexed citations
12.
Fiala, Pavel, et al.. (2003). Tracheal stenosis complicated with tracheoesophageal fistula. European Journal of Cardio-Thoracic Surgery. 25(1). 127–130. 16 indexed citations
13.
Kr̆epela, E, et al.. (1999). Regulation of Cathepsin B Activity by Cysteine and Related Thiols. Biological Chemistry. 380(5). 541–51. 11 indexed citations
14.
Kr̆epela, E, et al.. (1998). Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.. PubMed. 45(5). 318–31. 22 indexed citations
15.
Kr̆epela, E, et al.. (1995). Multiple forms of cathepsin b in human lung cancer. International Journal of Cancer. 61(1). 44–53. 15 indexed citations
16.
Kasafírek, E, et al.. (1992). Two-step generation of spirocyclic dipeptides from linear peptide ethyl ester precursors. Life Sciences. 50(3). 187–193. 11 indexed citations
17.
Šedo, Aleksi, E Kr̆epela, & E Kasafírek. (1991). Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumours and lung parenchyma. Journal of Cancer Research and Clinical Oncology. 117(3). 249–253. 33 indexed citations
18.
Sloane, Bonnie F., Kamiar Moin, E Kr̆epela, & Jurij Rozhin. (1990). Cathepsin B and its endogenous inhibitors: the role in tumor malignancy. Cancer and Metastasis Reviews. 9(4). 333–352. 163 indexed citations
19.
Šedo, Aleksi, E Kr̆epela, & E Kasafírek. (1989). A kinetic fluorometric assay of dipeptidyl peptidase IV in viable human blood mononuclear cells. Biochimie. 71(6). 757–761. 20 indexed citations
20.
Kr̆epela, E, E Kasafírek, J. Vičar, & J Kraml. (1983). An assay of dipeptidyl peptidase IV activity in human serum and serum of pregnant women with glycyl-L-proline-1-naphthylamide and other glycyl-L-proline-arylamides as substrates.. PubMed. 32(4). 334–45. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuzo Furuya Breakdown of academic impact, for papers by Bianca Maria Veneziani Breakdown of academic impact, for papers by Yoko Takagi Breakdown of academic impact, for papers by Lars Damstrup Breakdown of academic impact, for papers by Grégoire Prévost Breakdown of academic impact, for papers by Daqing Wu Breakdown of academic impact, for papers by M Mabry Breakdown of academic impact, for papers by George Van Buren Breakdown of academic impact, for papers by Peter Shintaku Breakdown of academic impact, for papers by Julie Litz
Rankless by CCL
2026